Walter Fritz
Family Medicine · Knox, INNPI 1851330112
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $676 and has fallen 94.3% since, to $38 in 2024.
Across 152 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$461
- Pfizer$156
- Vanda Pharmaceuticals Inc.$149
- Mylan Specialty L.p.$148
- Sunovion Pharmaceuticals Inc.$135
- Otsuka America Pharmaceutical, Inc.$126
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,460100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $461 |
| Pfizer | 10 | $156 |
| Vanda Pharmaceuticals Inc. | 7 | $149 |
| Mylan Specialty L.p. | 8 | $148 |
| Sunovion Pharmaceuticals Inc. | 8 | $135 |
| Otsuka America Pharmaceutical, Inc. | 8 | $126 |
| GSK | 9 | $120 |
| Johnson & Johnson | 7 | $114 |
| Bayer | 5 | $112 |
| Novo Nordisk | 7 | $111 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $107 |
| Electromed, Inc. | 6 | $93 |
| Lilly USA, LLC | 6 | $78 |
| Biohaven Pharmaceuticals, Inc. | 4 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $48 |
| Astellas Pharma US Inc | 3 | $47 |
| Dexcom, Inc. | 3 | $46 |
| Esperion Therapeutics, Inc. | 3 | $41 |
| Almatica Pharma LLC | 3 | $41 |
| Exact Sciences | 2 | $39 |
| Boehringer Ingelheim | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| AstraZeneca | 2 | $25 |
| Sanofi-aventis U.S. LLC | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Amgen | 1 | $14 |
| Philips North America LLC | 1 | $14 |
| Lundbeck LLC | 1 | $13 |
How this compares
$2,460 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,380 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $783 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $502 |
| Escitalopram Oxalate | 18 | $345 |
| Mirtazapine | 13 | $313 |
| Levothyroxine Sodium | 20 | $297 |
| Valsartan | 15 | $271 |
| Famotidine | 11 | $258 |
| Metoprolol Succinate | 24 | $249 |
| Atorvastatin Calcium | 25 | $246 |
| Lisinopril | 19 | $187 |
| Pantoprazole Sodium | 22 | $171 |
| Rosuvastatin Calcium | 23 | $156 |
| Amlodipine Besylate | 38 | $150 |
| Carvedilol | 17 | $135 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Knox
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.